Image

Preliminary Effectiveness of Enhanced Text Message + Incentives

Preliminary Effectiveness of Enhanced Text Message + Incentives

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

This study is a preliminary evaluation of a smoking cessation intervention designed for pregnant women that combines text message support and financial incentives.

The aims of this study are to determine the preliminary feasibility and acceptability of text message + incentives (intervention) vs. text message only (control).

Description

Pregnant women who smoke and their babies are exposed to known carcinogens and smoking is associated with adverse maternal and birth outcomes. Low-income pregnant women are particularly at risk because they have higher smoking rates and are less likely to quit. Despite continued smoking, most pregnant smokers do not receive smoking cessation counseling and only one in 10 receive referrals to cessation services or follow-up care. Incentives for smoking cessation yield the highest effect sizes of any intervention for pregnant women. Most prior studies evaluating incentives for smoking cessation in this population have used time and resource-intensive in-person visits to verify abstinence for contingent reinforcement. The long-term goal of this research is to reduce the burden of tobacco use by developing and evaluating a highly scalable, effective intervention to support smoking cessation during pregnancy.

Eligibility

Inclusion Criteria:

  • Pregnant women aged: 18+
  • Enrolled in the Special Supplemental Nutrition Program for women, Infants, and Children (WIC) or Medicaid (or applied/applying)
  • Self-reported current daily smokers
  • Able to communicate in English
  • Access to a mobile phone capable of receiving text messages

Exclusion Criteria:

  • Not at all interested in quitting
  • Smoke less than 24 days in the past month
  • Greater than 30 weeks gestation

Study details
    Smoking Cessation
    Pregnancy

NCT07420621

University of Kansas Medical Center

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.